People prescribed GLP-1 medications are more likely to start and stop than most people assume, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗